Lisa Phelan spoke to Global Competition Review about the Department of Justice (DOJ) Antitrust Division announcing the withdrawal of three key policy statements blessing “safety zones” for rivals in the healthcare industry to share competitively-sensitive information.
According to Lisa, many companies are unsure which information-sharing practices will now be considered unlawful.
The fact that the DOJ withdrew the policy trio and “refused to offer anything in its place [is] leaving a sort of grey area that has people very nervous,” Lisa said, noting that most companies want to try to comply with the laws.
Lisa added that companies and their representatives would like the agency to provide additional guidance on how to best comply absent the policy statements. However, the DOJ will probably not churn out new guidance on information sharing in the future, she said.
Read the full article (subscription may be required).